Read + Share
Amedeo Smart
Independent Medical Education
Elaraby O, El-Feky D, Hung JH, Akhavanrezayat A, et al. Ocular Inflammation as a Risk Factor for Anti-Adalimumab Antibodies in Patients with Autoimmune Diseases Treated with Adalimumab. Ophthalmology 2026 May 26:S0161-6420(26)00376.PMID: 42203133
Email
LinkedIn
Privacy Policy